PDCD1 and neoplasm: Activation of immune checkpoint cascades such as those controlled by cytotoxic T lymphcytes associated protein 4 (CTLA-4) or programmed cell death protein 1 (PD-1) and its ligand (PD-L1) results in inactivation of tumor-specific T cells and immune evasion.